| Tretinoin | Approved Investigational Nutraceutical | EPB41L1 | 2036 |
upregulated | Tretinoin results in increased expression of EPB41L1 mRNA | 20q11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | EPB41L3 | 23136 |
upregulated | Tretinoin results in increased expression of EPB41L3 mRNA | 18p11.31 | |
| Tretinoin | Approved Investigational Nutraceutical | EPB41L4A | 64097 |
upregulated | Tretinoin results in increased expression of EPB41L4A mRNA | 5q22.1-q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | EPB41L4A-AS1 | 114915 |
downregulated | Tretinoin results in decreased expression of EPB41L4A-AS1 mRNA | 5q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EPB41L4A-AS2 | 54508 |
upregulated | Tretinoin results in increased expression of EPB41L4A-AS2 mRNA | 5q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | EPB41L5 | 57669 |
upregulated | Tretinoin results in increased expression of EPB41L5 mRNA | 2q14.2 | |
| Tretinoin | Approved Investigational Nutraceutical | EPCAM | 4072 |
upregulated | Tretinoin results in increased expression of EPCAM mRNA | 2p21 | |
| Tretinoin | Approved Investigational Nutraceutical | EPDR1 | 54749 |
upregulated | Tretinoin results in increased expression of EPDR1 mRNA | 7p14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EPHA3 | 2042 |
downregulated | Tretinoin results in decreased expression of EPHA3 mRNA | 3p11.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EPHA4 | 2043 |
downregulated | Tretinoin results in decreased expression of EPHA4 mRNA | 2q36.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EPHA7 | 2045 |
downregulated | Tretinoin results in decreased expression of EPHA7 mRNA | 6q16.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EPHA8 | 2046 |
downregulated | Tretinoin results in decreased expression of EPHA8 mRNA | 1p36.12 | |
| Tretinoin | Approved Investigational Nutraceutical | EPHB3 | 2049 |
upregulated | Tretinoin results in increased expression of EPHB3 mRNA | 3q27.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EPHB6 | 2051 |
downregulated | Tretinoin results in decreased expression of EPHB6 mRNA | 7q34 | |
| Tretinoin | Approved Investigational Nutraceutical | EPOP | 100170841 |
downregulated | Tretinoin results in decreased expression of EPOP mRNA | 17q12 | |
| Tretinoin | Approved Investigational Nutraceutical | EPOR | 2057 |
upregulated | Tretinoin results in increased expression of EPOR mRNA | 19p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | EPS8 | 2059 |
upregulated | Tretinoin results in increased expression of EPS8 mRNA | 12p12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | EPS8L2 | 64787 |
upregulated | Tretinoin results in increased expression of EPS8L2 mRNA | 11p15.5 | |
| Tretinoin | Approved Investigational Nutraceutical | EPX | 8288 |
downregulated | Tretinoin results in decreased expression of EPX mRNA | 17q22 | |
| Tretinoin | Approved Investigational Nutraceutical | ERBB2 | 2064 |
downregulated | Tretinoin results in decreased expression of ERBB2 mRNA | 17q12 | |
| Tretinoin | Approved Investigational Nutraceutical | ERBB4 | 2066 |
downregulated | Tretinoin results in decreased expression of ERBB4 mRNA | 2q34 | |
| Tretinoin | Approved Investigational Nutraceutical | ERBB4 | 2066 |
upregulated | Tretinoin results in increased expression of ERBB4 mRNA | 2q34 | |
| Tretinoin | Approved Investigational Nutraceutical | ERCC2 | 2068 |
upregulated | Tretinoin results in increased expression of ERCC2 mRNA | 19q13.32 | |
| Tretinoin | Approved Investigational Nutraceutical | ERCC8 | 1161 |
downregulated | Tretinoin results in decreased expression of ERCC8 mRNA | 5q12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EREG | 2069 |
upregulated | Tretinoin results in increased expression of EREG mRNA | 4q13.3 | |